Literature DB >> 3100449

Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon.

L D Sibley, J L Krahenbuhl.   

Abstract

Mycobacterium leprae grows to enormous numbers in the nu/nu mouse footpad, producing granulomas resembling those of lepromatous leprosy in humans. Footpad granuloma cells gorged with M. leprae were established in primary cell culture to examine their functional capabilities. These cells were classified as macrophages by the following criteria: positive staining for nonspecific esterase, reduction of Nitro Blue Tetrazolium during phagocytosis of Candida albicans, possession of Fc receptors, and possession of Mac-1 antigen. Footpad macrophages also phagocytized and supported the intracellular growth of Toxoplasma gondii. However, unlike peritoneal macrophages, footpad macrophages could not be activated to kill or inhibit T. gondii by macrophage-activating factor produced by mitogen-stimulated spleen cells or by recombinant gamma interferon. Thus, although the lepromatous macrophages appeared to be normal in many of their functions, they were defective in response to macrophage-activating signals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100449      PMCID: PMC260348          DOI: 10.1128/iai.55.2.446-450.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.

Authors:  S W Russell; A T McIntosh
Journal:  Nature       Date:  1977-07-07       Impact factor: 49.962

2.  Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

Authors:  C F Nathan; G Kaplan; W R Levis; A Nusrat; M D Witmer; S A Sherwin; C K Job; C R Horowitz; R M Steinman; Z A Cohn
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

Review 3.  Immunological aspects of leprosy--present status.

Authors:  T Godal
Journal:  Prog Allergy       Date:  1978

4.  Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.

Authors:  J Convit; M E Pinardi; G Rodríguez Ochoa; M Ulrich; J L Avila; M Goihman
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

5.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

6.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Leukocyte antimicrobial function in patients with leprosy.

Authors:  D J Drutz; M J Cline; L Levy
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro.

Authors:  H Hirschberg
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

9.  Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity.

Authors:  A F Amsden; D L Boros
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

10.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  24 in total

1.  Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis.

Authors:  A M Soares; S A Calvi; M T Peraçoli; A C Fernandez; L A Dias; A R Dos Anjos
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae.

Authors:  S G Franzblau; A N Biswas; E B Harris
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 3.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

4.  Murine experimental leprosy: Evaluation of immune response by analysis of peritoneal lavage cells and footpad histopathology.

Authors:  Fátima Regina Vilani-Moreno; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Suzana Madeira Diório; Sônia Maria Usó Ruiz Silva; Patrícia Sammarco Rosa; Andréa de Faria Fernandes Belone; Cleverson Teixeira Soares; José Roberto Pereira Lauris; Sílvia Cristina Barboza Pedrini
Journal:  Int J Exp Pathol       Date:  2019-05-24       Impact factor: 1.925

5.  Induction of antigen-specific immunity and tolerance to Mycobacterium leprae in Lewis rats.

Authors:  M A Winters; R C Humphres
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 6.  Hansen's disease.

Authors:  R H Gelber
Journal:  West J Med       Date:  1993-06

Review 7.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.

Authors:  L B Adams; Y Fukutomi; J L Krahenbuhl
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.

Authors:  M G Stevens; G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Isolation and partial characterization of glycolipid fractions from Mycobacterium avium serovar 2 (Mycobacterium paratuberculosis 18) that inhibit activated macrophages.

Authors:  M E Hines; J M Jaynes; S A Barker; J C Newton; F M Enright; T G Snider
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.